Imagion Biosystems Limited (ASX:IBX)
Australia · Delayed Price · Currency is AUD 0.0200
0.00 (0.00%)
At close: Mar 6, 2026
Imagion Biosystems Revenue
In the year 2025, Imagion Biosystems had annual revenue of 73.03K AUD, down -97.26%. Imagion Biosystems had revenue of 47.30K in the half year ending December 31, 2025, a decrease of -98.90%.
Revenue
73.03K
Revenue Growth
-97.26%
P/S Ratio
134.35
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.81M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 73.03K | -2.59M | -97.26% |
| Dec 31, 2024 | 2.67M | -2.31M | -46.38% |
| Dec 31, 2023 | 4.97M | 1.90M | 61.87% |
| Dec 31, 2022 | 3.07M | 215.36K | 7.54% |
| Dec 31, 2021 | 2.86M | 158.60K | 5.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Healius | 1.37B |
| Integral Diagnostics | 767.82M |
| Australian Clinical Labs | 737.49M |
| Monash IVF Group | 269.39M |
| Genetic Signatures | 19.94M |
| Cryosite | 15.75M |
| Microba Life Sciences | 14.90M |
| Genetic Technologies | 9.17M |